Overview

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of various doses of nebivolol in patients with mild to moderate hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Mylan Bertek Pharmaceuticals
Treatments:
Nebivolol